A PLP splicing abnormality is associated with an unusual presentation of PMD.
We report that a deletion of 19 base pairs (bp) in intron 3 of the proteolipid protein (PLP/DM20) gene causes a neurological disease characterized by mild developmental delay, followed by progressive decline of acquired motor and cognitive milestones. The clinical features are associated with mild delay in myelination demonstrated by magnetic resonance imaging studies and with ongoing demyelination and axonal loss demonstrated by magnetic resonance spectroscopy. We demonstrate that the purine-rich 19bp element regulates PLP-specific splice site selection in transient transfections of chimeric constructs into cultured oligodendrocytes. Runs of 4 and 5 Gs centered in the 19bp element are critical for efficient PLP-specific splicing. The intronic element is sequence specific in oligodendrocytes and is not a repressor of PLP-specific splicing in nonglial cells. These data support the conclusion that deletion of the 19bp purine-rich region in PLP intron 3 causes a reduction in PLP message and protein, which affects myelin stability and axonal integrity.
D000818:Animals; D001483:Base Sequence; D001921:Brain / Q000473:pathology; D019556:COS Cells; D002874:Chromosome Mapping; D005260:Female; D017353:Gene Deletion; D006801:Humans; D007438:Introns / Q000235:genetics; D008279:Magnetic Resonance Imaging; D008969:Molecular Sequence Data; D018991:Myelin Proteolipid Protein / Q000235:genetics*; D020371:Pelizaeus-Merzbacher Disease / Q000235:genetics* / Q000473:pathology; D010641:Phenotype; D012326:RNA Splicing; D012045:Regulatory Sequences, Nucleic Acid / Q000235:genetics; D014162:Transfection
D018991:Myelin Proteolipid Protein